Home › Open-Angle Glaucoma › Pennsylvania › Philadelphia
Open-Angle Glaucoma clinical trials in Philadelphia, PA
4 studies for Open-Angle Glaucoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
RecruitingPhase 3
- Wills Eye Hospital /ID# 268569, Philadelphia
- Ophthalmic Partners of PA /ID# 276059, Bala-Cynwyd · 5 mi away
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Recruiting
- Scheie Eye Institute, Philadelphia
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
RecruitingPhase 4
- Wills Eye Hosital Glaucoma Dept., Philadelphia
A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
RecruitingObservational study
- Shafer Vision Institute, Plymouth Meeting · 12 mi away
Open-Angle Glaucoma trials in other cities
- Kenosha, WI5 studies
- Houston, TX4 studies
- Santa Rosa, CA4 studies
- El Paso, TX3 studies
- Oklahoma City, OK3 studies
- Boston, MA3 studies
- Austin, TX3 studies
- Roswell, GA3 studies
- Newport Beach, CA3 studies
- New York City, NY3 studies
- Dallas, TX3 studies
Other studies in Philadelphia
- Cancer (all types)57 studies
- Breast Cancer51 studies
- Non-Small Cell Lung Cancer49 studies
- Ovarian Cancer47 studies
- Metastatic Cancer42 studies
- Colorectal Cancer41 studies
- Prostate Cancer41 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia33 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Pancreatic Cancer26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.